E Albonetti
Overview
Explore the profile of E Albonetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
10
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez M, Albonetti E, Siddiqui A, Farabollini F, Wilson C
Pharmacol Biochem Behav
. 1996 May;
54(1):195-203.
PMID: 8728558
Males, females, neonatally androgenized females, and neonatally castrated males were treated over the second week of life with 0.25 mg/kg of either the 5-HT2 agonist 1-(2,5-dimethoxy-3-iodophenyl)-2-aminopropane HCl (DOI), the 5-HT2...
2.
Albonetti E, Gonzalez M, Siddiqui A, Wilson C, Farabollini F
Pharmacol Biochem Behav
. 1996 May;
54(1):189-93.
PMID: 8728557
5-hydroxytryptamine (5-HT) interacts with testosterone (T) in the development of a number of neuronal systems controlling sexually dimorphic adult behaviours. In this report, we investigated this interaction on the organization...
3.
Gonzalez M, Farabollini F, Albonetti E, Wilson C
Pharmacol Biochem Behav
. 1994 Mar;
47(3):591-601.
PMID: 8208779
Two 5-hydroxytryptamine2 (5-HT2) agents, ritanserin and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI) (both at 0.25 mg/kg IP), were administered to castrated males bearing graded testosterone implants (empty, 2.5-, 5-, and 10-mm length) and...